Literature DB >> 15346998

New paradigms for treating elderly patients with cancer: the comprehensive geriatric assessment and guidelines for supportive care.

Lodovico Balducci1.   

Abstract

Strategies for treating cancer are evolving to address the growing number of elderly patients with cancer. Older patients have highly variable physiologic ages, and their treatment should be individualized for optimal outcomes. Treatment paradigms should also take into account the diversity of patients' life expectancy, functional reserve, social support, and personal preference. A Comprehensive Geriatric Assessment (CGA) is a useful tool for estimating life expectancy and tolerance of treatment and for identifying reversible factors that may interfere with cancer treatment, including depression, malnutrition, anemia, neutropenia, and lack of caregiver support. Adopting a common language to describe older patients may facilitate the design and analysis of studies to determine effective drugs and care strategies for them. Information from a CGA can guide the prescription of potentially curative therapy, determine the best use of supportive care agents, and help identify frail patients for whom palliative care is the best option. There is evidence in a number of settings that the routine use of a CGA has a positive effect on health outcomes by reducing hospitalizations, preserving functional independence, and preventing geriatric syndromes. Guidelines for supportive care are also important in treating elderly patients with cancer. Pain, caused by cancer or its treatment, is prevalent, and guidelines for its assessment and treatment should be implemented to improve quality of life. Toxicities such as neutropenia and mucositis should be managed aggressively. Growth factors reduce the incidence and severity of neutropenia and its complications in older patients, particularly when they are administered in the early cycles of chemotherapy. The development of effective strategies for the management of toxicity caused by anticancer drugs may help the elderly, as much as younger patients, expect and look forward to a positive outcome with their treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15346998

Source DB:  PubMed          Journal:  J Support Oncol        ISSN: 1544-6794


  15 in total

1.  Mixed method exploration of the medical, service-related, and emotional reasons for emergency room visits of older cancer patients.

Authors:  Bich-Lien Nguyen; Dominique Tremblay; Luc Mathieu; Danielle Groleau
Journal:  Support Care Cancer       Date:  2015-12-23       Impact factor: 3.603

Review 2.  A systematic review of unmet needs of newly diagnosed older cancer patients undergoing active cancer treatment.

Authors:  M T E Puts; A Papoutsis; E Springall; A E Tourangeau
Journal:  Support Care Cancer       Date:  2012-04-04       Impact factor: 3.603

Review 3.  Treatment of colorectal cancer in the elderly.

Authors:  Monica Millan; Sandra Merino; Aleidis Caro; Francesc Feliu; Jordi Escuder; Tani Francesch
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

4.  How to treat old MCL patients: one size fits it all?

Authors:  Martin Dreyling; Simone Ferrero
Journal:  Blood       Date:  2014-08-21       Impact factor: 22.113

5.  Linking the Ohio Cancer Incidence Surveillance System with Medicare, Medicaid, and Clinical Data from Home Health Care and Long Term Care Assessment Instruments: Paving the Way for New Research Endeavors in Geriatric Oncology.

Authors:  Siran M Koroukian
Journal:  J Registry Manag       Date:  2008

Review 6.  Computational oncology--mathematical modelling of drug regimens for precision medicine.

Authors:  Dominique Barbolosi; Joseph Ciccolini; Bruno Lacarelle; Fabrice Barlési; Nicolas André
Journal:  Nat Rev Clin Oncol       Date:  2015-11-24       Impact factor: 66.675

7.  Feasibility of computer-based self-administered cancer-specific geriatric assessment in older patients with gastrointestinal malignancy.

Authors:  Nadine J McCleary; Devin Wigler; Donna Berry; Kaori Sato; Thomas Abrams; Jennifer Chan; Peter Enzinger; Kimmie Ng; Brian Wolpin; Deborah Schrag; Charles S Fuchs; Arti Hurria; Jeffrey A Meyerhardt
Journal:  Oncologist       Date:  2013-01-03

8.  Spanish Society of Medical Oncology consensus for the use of haematopoietic colony-stimulating factors in cancer patients.

Authors:  Alfredo Carrato; Luis Paz-Ares Rodríguez; Alvaro Rodríguez Lescure; Ana M Casas Fernández de Tejerina; Eduardo Díaz Rubio García; Pedro Pérez Segura; Manuel Constenla Figueiras; Rocío García Carbonero; José Gómez Codina; Ana Lluch Hernández; José Pablo Maroto Rey; Miguel Martín Jiménez; José Ignacio Mayordomo Cámara; José Andrés Moreno Nogueira; Antonio Rueda Domínguez
Journal:  Clin Transl Oncol       Date:  2009-07       Impact factor: 3.405

Review 9.  Frontline Treatment for Older Patients with Mantle Cell Lymphoma.

Authors:  Haige Ye; Aakash Desai; Dongfeng Zeng; Jorge Romaguera; Michael L Wang
Journal:  Oncologist       Date:  2018-06-12

10.  Older cancer patients' information and support needs surrounding treatment: An evaluation through the eyes of patients, relatives and professionals.

Authors:  Elise R Posma; Julia C M van Weert; Jesse Jansen; Jozien M Bensing
Journal:  BMC Nurs       Date:  2009-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.